MediPines Corporation
Yorba Linda
About MediPines Corporation
MediPines is a pioneer and market leader in non-invasive pulmonary gas exchange technology. The company’s mission is to advance respiratory medicine by providing physiology-based cardiorespiratory devices that enhance clinical effectiveness and achieve superior patient outcomes. The MediPines AGM100 is an industry award winning, FDA-cleared, advanced pulmonary gas exchange technology that exclusively provides Oxygen Deficit, a surrogate for the alveolar to arterial oxygen difference (AaDO2), as well as blood oxygen level (gPaO2), lung carbon dioxide level (PETCO2), and other sensitive measurements of pulmonary gas exchange, relevant for patients with respiratory and cardiac complications. AGM100 is used by medical providers and clinicians to raise diagnostic accuracy, improve treatment decisions, and accelerate healthcare decision making. MediPines is located in Orange County, California. The company is a FDA registered, California medical device manufacturing licensed (CDPH). All products are manufactured in a MDSAP/ISO13485 certified facility, the globally harmonized quality standard for medical devices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $7.4M
- Last round: Series Unknown (Sep 2021)
- Website: medipines.com
- Phone: (949)398-4670
Industries & Categories
Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/medipines-corporation-140729 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.